TRERF1 and type 1 diabetes mellitus: Of note, the lack of RAPA seemed to be beneficial in T1D as no deleterious impact on beta-cell function was observed under IL-2 treatment alone, irrespectively of dose, confirming its toxic effect on beta cells [90,91,92].